ArticleMultiple sclerosis journal - experimental, translational and clinical2021

Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.

Peter Rieckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.